Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model
about
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilitiesIs lipid signaling through cannabinoid 2 receptors part of a protective system?The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegenerationImmune mechanisms in cerebral ischemic toleranceTime-Dependent Protection of CB2 Receptor Agonist in StrokeCB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune DysregulationCannabinoid CB2 receptor (CB2R) stimulation delays rubrospinal mitochondrial-dependent degeneration and improves functional recovery after spinal cord hemisection by ERK1/2 inactivation.Possible Anandamide and Palmitoylethanolamide involvement in human stroke.Brain CB₂ Receptors: Implications for Neuropsychiatric Disorders.The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in miceModulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and stroke.Cannabinoid receptor 2 signaling does not modulate atherogenesis in miceIn vitro and in vivo characterization of the new analgesic combination Beta-caryophyllene and docosahexaenoic Acid.The cannabinoid WIN55,212-2 protects against oxidized LDL-induced inflammatory response in murine macrophages.Deficiency of PAR4 attenuates cerebral ischemia/reperfusion injury in miceCB2 Cannabinoid receptors as a therapeutic target-what does the future hold?Cannabinoids in experimental stroke: a systematic review and meta-analysis.Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury.Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosisCB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion.Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions.The dual neuroprotective-neurotoxic profile of cannabinoid drugs.Endocannabinoids and traumatic brain injuryN-arachidonoyl-L-serine is neuroprotective after traumatic brain injury by reducing apoptosis.Endocannabinoid system in cardiovascular disorders - new pharmacotherapeutic opportunities.Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotectionModulation of inflammatory responses by a cannabinoid-2-selective agonist after spinal cord injuryNon-Selective Cannabinoid Receptor Antagonists, Hinokiresinols Reduce Infiltration of Microglia/Macrophages into Ischemic Brain Lesions in Rat via Modulating 2-Arachidonolyglycerol-Induced Migration and Mitochondrial Activity.The endocannabinoid system: an overview.β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner.CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury.Update on the role of cannabinoid receptors after ischemic stroke.A CB2-Selective Cannabinoid Suppresses T-Cell Activities and Increases Tregs and IL-10Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors.A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injuryReduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2 after neonatal stroke.Targeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversies.Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression.Latest advances in novel cannabinoid CB(2) ligands for drug abuse and their therapeutic potential.
P2860
Q24623282-9028C043-F2B0-4B08-BEA7-74668CD3D28FQ24633122-286C7FA9-BCCB-43BA-BC1C-08F878ACD1E4Q24651712-68F52C43-506E-45F4-979B-F15E07C66D08Q27022067-E18DDAC1-5D90-4B28-A30A-D182AA8439F3Q27302924-A30E95C8-922C-4494-BE94-8CAAB8F709B1Q28072822-18DABE94-4B3B-48D6-AEE5-D65DDB3F148BQ30661637-47905B41-7961-4DBB-B92A-B811AEEB4D02Q33446413-5714ADF4-B796-42DB-B574-5E64FE429CB0Q33664105-70E8E2B8-9DD2-42E4-AEAB-C32AC37D1B2FQ33703839-68744BB7-F930-4668-A1D8-5D750E29DB6FQ33793559-CA95CDD2-4237-4F1D-B862-618F284635B0Q33889311-85520E26-17DA-408D-8689-8FC8FF2FF5ECQ33944886-841476E8-AA88-4A9A-9215-F3AF7B88DC8FQ33993080-BCA28C4D-527E-4B81-A8BC-2B47782AC238Q34171082-57006B9D-81BD-4317-B7BB-5CBF67FE6F0CQ34186015-7672157A-58BB-4A27-82E9-5547A327572FQ34452972-5ECB8378-23A1-4FE6-9D8A-0316358FFEA4Q34591087-D73662A4-48E5-46E5-A598-7F789AD02405Q34655802-A8B486EF-0C3B-4B83-9C1C-63BCF9A848C4Q34657057-02B93AD9-7E54-44C6-8D7A-E5E3B49F78F3Q34851941-95CFF2B0-2A86-42F5-A49F-A996B8FE7371Q34993393-9B7CBE34-D2E1-46E5-8131-61FC2FBAFB67Q35193273-4BBBB192-3600-4BC6-B903-4BCA61CA4394Q35193282-B9E968BF-2322-4EE1-ABB4-F22EC907EB93Q35208016-F1E5E6A1-8E10-46F7-ADD9-220894860DCAQ35228889-34F89BC0-6845-40D5-B6DF-811C1BB8F6D3Q35499568-52EA07A1-0B53-4A4A-A7F4-B5DC4CC822E0Q35606180-C1CE8F36-2424-47B2-B0E2-85BC755D973AQ35827422-BDEBEA83-CC5B-449B-AD5F-6F0BC76F9DD8Q35828434-404065A9-32ED-4418-B10D-9B25D749CFE3Q35854652-72813008-3DD8-4AC9-8CF3-0A31534FF6FCQ35870490-95704956-985D-4B89-8C5A-095C1452891AQ35915645-A6B3E19E-7445-4885-BB2D-1D33F329FC48Q35927832-9A4D26B0-F317-4503-A776-EA8B7E182B05Q36176486-1BCDCFBD-67BD-4174-8406-794CDA29AB42Q36176499-FFF780C0-A7F3-4E19-AC02-85B3E11B9FFAQ36247115-57C1BEA2-DDA2-4876-A685-F8A967053CEBQ36346915-7EE4E650-68B3-49AF-913B-E8CAA289F1B1Q36370835-6848AFE2-DAFC-434F-BE97-A0F088F751C1Q36408464-15F171BB-856D-4F3F-8F3E-41766B7BB140
P2860
Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 January 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cannabinoid CB
@nl
Cannabinoid CB(2) receptor act ...... cal ischemia/reperfusion model
@en
type
label
Cannabinoid CB
@nl
Cannabinoid CB(2) receptor act ...... cal ischemia/reperfusion model
@en
prefLabel
Cannabinoid CB
@nl
Cannabinoid CB(2) receptor act ...... cal ischemia/reperfusion model
@en
P2093
P2860
P921
P356
P1476
Cannabinoid CB(2) receptor act ...... cal ischemia/reperfusion model
@en
P2093
Jack I Jallo
Martin W Adler
Ming Zhang
Raj K Razdan
Ronald F Tuma
P2860
P304
P356
10.1038/SJ.JCBFM.9600447
P577
2007-01-24T00:00:00Z